Information Provided By: 
Fly News Breaks for October 27, 2016
EXAS
Oct 27, 2016 | 07:27 EDT
Canaccord analyst Mark Massaro noted Exact Sciences reported solid Q3 results and believes the post-earnings reaction in the stock is overblown. The analyst believes the new share level represents an attractive entry point for investors as the company executes at a high level and they beat estimates on every metric. Massaro believes the shares reverts back to the $20 range quickly and reiterated his Buy rating and $24 price target on Exact Sciences shares.
News For EXAS From the Last 2 Days
There are no results for your query EXAS
